Monday, July 13, 2026
The indices are broadcast in real time.
Prices are delayed by 15 minutes
21/05/2025
| TAZI MOHAMMED | 17,59 % |
|---|---|
| DIVERS ACTIONNAIRES | 12,40 % |
| TAZI Najia | 9,81 % |
| TAZI Lamiae | 8,19 % |
| TAZI Selma | 6,94 % |
| BERRADA Mohammed Karim | 6,71 % |
| BERRADA BAHIA | 6,50 % |
| BERRADA Mohammed Amine | 6,41 % |
| TAHIRI GHALI Consort | 5,37 % |
| CHAOUI OMAR | 4,28 % |
| TAZI BADIA | 4,00 % |
| BERRADA HALIMA | 3,93 % |
| BERRADA Lina | 3,67 % |
| DIOURI Amal | 3,02 % |
| SEFRIOUI MOHAMMED | 1,16 % |
| TAZI Ali | 0,02 % |
| Total | 100,00 % |
Company information
| Company name | SOCIETE DE THERAPEUTIQUE MAROCAINE |
|---|---|
| Corporate address | Centre de Bouskoura. BP n° 1 -- Casablanca. |
| External auditors | PWC Maroc-Sarl / Fiduciaire de France et du Maroc |
| Date of creation | 26/01/1976 |
| Date of IPO | 21/02/2005 |
| Length of fiscal year | 12 |
| Social object | According to Article 3 of the company’s Articles of Association. its purpose both in Morocco and overseas is: representation. purchase and sale of any pharmaceutical. chemical. health-related. biological. veterinary. plant-based. cosmetic and scented produ |
Key figures (1)
2025 | 2024 | 2023 | |
|---|---|---|---|
| Consolidated accounts | Yes | Yes | No |
| Share capital | 380 336 400,00 | 360 000 000,00 | 360 000 000,00 |
| Equity | 2 649 675 000,00 | 1 707 312 000,00 | 1 518 510 000,00 |
| Number of titles(2) | 7 606 728 | 7 200 000 | 7 200 000 |
| Sales figures | 3 225 670 000,00 | 2 815 902 000,00 | 2 485 996 000,00 |
| Operating result | 626 524 000,00 | 512 092 000,00 | 388 546 000,00 |
| Net income (4) | 385 526 000,00 | 315 288 000,00 | 262 758 000,00 |
At the end of the financial year.
All lines of action combined.
(3) Equity of the consolidated group for companies publishing consolidated accounts
Net income Group share for companies publishing consolidated accounts.
Ratio
| Ratios | 2025 | 2024 | 2023 |
|---|---|---|---|
| BPA | 50,68 | 43,79 | 36,49 |
| ROE (in %) | 14,55 | 18,47 | 17,30 |
| Payout (in %) | 65,58 | - | 46,58 |
| Dividend yield (in %) | 1,80 | - | 1,79 |
| PER | 36,50 | 21,12 | 26,06 |
| PBR | 5,31 | 3,90 | 4,51 |
Investor Relations - Contacts
Contacts
Adnane HILAL
Phone
0522 43 70 40 (LG)
Fax
0522 43 70 45
Corporate Website
Capital increase
Dividend
Bond issue
SOCIETE DE THERAPEUTIQUE MAROCAINE
2026-05-25
SOCIETE DE THERAPEUTIQUE MAROCAINE
2026-05-14
https://www.casablanca-bourse.com/undefined//live-market/emetteurs/SOT210205
Tuesday, July 14, 2026 01:41:59